Skip to main content
Toggle search
Circassia
  • Home
  • Company
    • About us
    • Board of Directors
    • Management team
    • Corporate Responsibility
  • Technologies

    Circassia Technologies

    NIOX® FeNO testing

    Our NIOX® products accurately measure the concentration of fractional exhaled nitric oxide (FeNO) in asthma patients’ breath to help evaluate underlying airway inflammation.

    • Technologies
  • Products
  • Pipeline

    Pipeline Products

    LungFit PH

    • LungFit PH
    • Commercial opportunity
  • Investors
    • Regulatory news
    • Share price summary
    • Share price chart
    • Analyst coverage
    • Financial reports
    • Financial calendar
    • Registrars
    • AIM rule 26
    • Warning to shareholders
    • Email alerts
    • Investor contacts
    • Historic transactions
  • Careers

    Career Opportunities

    • UK Opportunities
    • US Opportunities
    • European Opportunities
    • China Opportunities
    • Opportunities
    • Job Applicant Privacy Notice
    • Careers contacts
  • Media

    Latest Press Release

    • Proposed transfer of assets to and termination of agreement with AstraZeneca for consideration to be set off against debt and accrued interest
      9th April 2020
    • Press releases
    • Presentations
    • Webcasts & audio
    • Image library
    • Media contacts
  • Contacts
    • Locations
    • Departments
    • Conferences

Contacts

  • Locations
  • Departments
  • Conferences

Locations

UK Head Office

US Headquarters

Swedish Headquarters

China Office

German Office

© 2020 Circassia. All Rights Reserved.

  • Legal notice
  • Modern slavery statement
  • Privacy Notice
  • Privacy shield policy
  • Cookie Settings
  • Site map